Today in Focus: WULF, SEER, Patience

StockAnalysis.com - I’ve been using Stock Analysis as an affordable but reliable method of looking at New and Upcoming IPOs, Earnings Calendars and most notably KPIs (Key Performance Indicators). Stock Analysis allows you to view the KPIs for many companies with up to date metrics and segments that you can cross reference against Earnings Results. This is incredibly important when understanding what metrics move a stock. At $65 per year it’s a no brainer. They’ve given me a discount code if you use IRISHBORNINVESTOR they will give you another 10% Off.

Market Condition: Choppy Rangebound Market. Be Patient.

Commentary: Market gapping up, burning those that piled in short on Thursday. This is how they do it to chop everyone up. Less is more as we make our way into earnings season. I think there will be plenty of opportunities to those who don’t burn themselves out chasing shadows! (I know, because in June that’s what I did!!).

Minimal amount of Earnings candidates this week though PENG on Tuesday evening has potential as it’s an AI play that has flagged out. I've highlighted a few more below but just out of process more than anything. Lot’s of strength in Biotech and a lot of good looking charts with catalysts coming up, as always will wait until catalysts hit to act.

In terms of Macro. A few things this week. ISM Services today, FED minutes on Wednesday and Home Sales on Thursday. Iran is old news so I’m ignoring any headlines on that front just focusing on the stocks.

Cautious today, in no rush to chase any names.

In Play

WULF: 20 Year Lease Agreement with Anthropic

Key Metrics WULF: Industry Group: Capital Markets, Market Cap: 12.13B, Float: 342.70, Short Interest: 31.71%, Days to Cover: 3.56, Earnings: 5/8/2026 8:30:00 AM, Exchange: NCM

Catalyst:

Executed a 20-year lease with Anthropic at its Justified Data campus (Hawesville, KY), stated to generate ~$19B of contracted revenue over the initial term; separately signed a definitive agreement to sell its 50.1% Abernathy JV stake to a Fluidstack-led investor group, monetizing a ~$450M investment "at a premium."

Chart was breaking down last week so this is a nice reversal. Above $25 is good, below it is bad. That is how I will look at this today. Worth nothing that this stock is a popular one amongst some of the well known retail newsletters such as Citrini.

Genuine catalyst with Dollar figures with a Top Tier named partner.

SEER: Activist Investor Battle + AI Biotech Theme

Key Metrics SEER: Industry Group: Biotechnology, Market Cap: 118.37M, Float: 36.19, Short Interest: 0.53%, Days to Cover: 0.41, Earnings: 5/13/2026 4:30:00 PM, Exchange: NMS

Catalyst:

Failed Life sciences company that is now involved in an activist investor battle. Basically there is an Activist that is trying to buy the company for $2.45 and the current CEO who is trying to do the same for $2.95. Stock has $90m Market Cap (before today) but is holding over $220m in cash so it’s trading more than 50% below NAV.

The board released a presentation today saying that they were focusing on Biotech AI (Theme) and the activist immediately hit back. This is all story and it seems like this is just a battle. Usually I avoid M&A but this has some potential to move today. Likely to be a one or two day play only if it can go.

Trade Updates:

Current Positions: APPS, ABVX, DFTX, BB

Major Economic Events this week.

Monday July 06 2026

Wednesday July 08 2026

Thursday July 09 2026

Tuesday After Hours: PENG

Wednesday Before Open: HELE

Wednesday After Hours: LEVI

Thursday Before Open: BYRN

Thursday After Hours: WDFC

Full Earnings Watchlist: TradingView Link

Flagged Charts: VERA, NAMS, INCY, FDMT, VTRS, ZYME, ARWR, CHRS, SION, AVBP, JAZZ, IONS, PRAX, ALMS, COGT, IMTX, ANNX, DTIL, IOVA, IMUX, VTVT, PCRX, IDYA, VIR, TEVA

There are so many Biotech charts setting up. I use BPIQ to track upcoming catalysts as well as see if a name is a hedge fund favorite or under owned. I never pre-position in Biotech’s or trade them on technicals alone. I always wait for the catalyst.

Note: Never front-run biotech catalysts. Wait for the catalyst to hit, then assess if the reaction is tradable. Dates are estimates and can shift.

Full H2 Biotech Watchlist: TradingView Link

This is my overall watchlist of strong stocks. I’m mainly looking at this to see how the market is setting up for next earnings.

Stocks in Play Watchlist (TradingView Link)

Have a Great Week!

Sean Sharpe

_{PS: There are many ways to trade stocks in play. It does not have to be the one that keeps going straight up and sometimes it doesn’t even have to be day one of the catalyst. Everyone must find a setup, timeframe and method that works for them. This list is supposed to educate on the criteria I use and the methods in which I find Stocks in Play. Yours may differ and that is completely okay.}